Creating new pain relief and mental health medications using unique chemical reactions
Official title: Rearrangement Reactions of Divinyldiaziridines for the Enantioselective Synthesis of Diazepines and Benzodiazepines
Funded at Rowan University · NIH-10730814 · Data updated 2026-11-12
This study is looking at new ways to make special medicines called diazepines and benzodiazepines, which can help with pain relief and mental health, by using unique chemical reactions to ensure they work well and are safe for you.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rowan University NIH-funded |
| Lab location | 1 site (Glassboro, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $449,777 |
| NIH project number | 1R15GM151707-01 |
| Project ID | NIH-10730814 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from chronic pain or mental health disorders who may benefit from new analgesic or anxiolytic medications.
✕Less likely to help
Patients who do not have chronic pain or mental health issues may not receive direct benefits from this research.
What this research studies
This research focuses on developing new methods to synthesize complex chemical compounds known as diazepines and benzodiazepines, which are important for creating effective pain relief and mental health medications. The researchers will explore specific chemical reactions involving divinyldiaziridines to produce these compounds in a way that ensures they are optically pure, meaning they have the desired properties for therapeutic use. The project consists of three main aims, each targeting different types of diazepines and benzodiazepines, utilizing innovative rearrangement reactions that have not been previously reported. This work aims to enhance the availability of effective analgesics and treatments for mental health disorders.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted medications for pain management and mental health conditions.
How similar studies have gone: While the specific chemical reactions being studied are novel, previous research has shown success in developing effective medications from similar chemical scaffolds.
Where this research is happening
-
Rowan University
Glassboro, United States Active
Researchers
- Principal investigator: Moura-Letts, Gustavo — Rowan University
- Study coordinator: Moura-Letts, Gustavo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.